Group 1 - The core viewpoint of the article highlights the recent performance and financial metrics of Meihao Medical (301363), including stock price movements and funding flows [1][2]. - As of January 19, 2026, Meihao Medical's stock closed at 32.45 yuan, experiencing a decline of 0.76% with a turnover rate of 3.74% and a trading volume of 139,500 hands, resulting in a transaction amount of 455 million yuan [1]. - In terms of funding flow on January 19, 2026, the main funds saw a net outflow of 3.97 million yuan, accounting for 0.87% of the total transaction amount, while retail investors experienced a net outflow of 1.89 million yuan, representing 4.14% of the total transaction amount [1]. Group 2 - For the first three quarters of 2025, Meihao Medical reported a main revenue of 1.194 billion yuan, reflecting a year-on-year increase of 3.28%, while the net profit attributable to shareholders decreased by 19.25% to 208 million yuan [2]. - The third quarter of 2025 showed a single-quarter main revenue of 462 million yuan, up 2.56% year-on-year, and a net profit attributable to shareholders of 93.90 million yuan, which is a 5.89% increase year-on-year [2]. - The company has a debt ratio of 11.43%, with investment income of 4.90 million yuan and financial expenses of -27.39 million yuan, alongside a gross profit margin of 39.34% [2].
股票行情快报：美好医疗（301363）1月19日主力资金净卖出396.78万元